Suppressor Lymphocyte Function During Attacks of Multiple Sclerosis

  • J. P. Antel
  • B. W. Arnason
Conference paper

Abstract

Multiple sclerosis (MS) is characterized by a relapsing and remitting course, particularly in the early phases of the disease. Tests of immune function conducted both on peripheral blood and spinal fluid strongly suggest that aberrant immune function occurs in MS patients. These aberrancies appear to be most striking during periods of active disease, although they may at times remain detectable during periods of clinical quiescence. For example, in studies of sensitivity of peripheral blood or cerebrospinal fluid (CSF) lymphocytes to myelin antigens, the most striking changes have been reported in patients with active disease. Similarly, changes in the percent of B and/or T cells in peripheral blood have been most evident when disease is active. Oger et al. [14] in contrast, have found that depressed numbers of avid T cells, probably representing a T-cell subset, are observed both when disease is active and when it is quiescent. Noronha et al. [13] have presented evidence that CSF lymphocytes of MS patients remain activated as measured by RNA/DNA content, even during seemingly quiescent disease. The possibility that MS is seldom “burned out” must be seriously entertained.

Keywords

Leukemia Corticosteroid Neurol Levamisole Concanavalin 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Abdou NI, Sagawa A, Pascual E, Hebert J, Sadeghee S (1976) Suppressor T-cell abnormality in idiopathic systemic lupus erythematosus. Clin Immunol Immunopathol 6:192PubMedCrossRefGoogle Scholar
  2. 2.
    Antel JP, Arnason BGW (1979) Suppressor cell function in man: Evidence for altered sensitivity of responder cells with age. Clin Immunol Immunopathol 13:119PubMedCrossRefGoogle Scholar
  3. 3.
    Antel JP, Arnason BGW, Medof ME (1979) Suppressor cell function in multiple sclerosis: Correlation with clinical disease activity. Ann Neurol 5:338PubMedCrossRefGoogle Scholar
  4. 4.
    Antel JP, Richman DP, Medof ME, Arnason BGW (1978) Lymphocyte function and the role of regulator cells in multiple sclerosis. Neurology 28:106PubMedGoogle Scholar
  5. 5.
    Antel JP, Weinrich M, Arnason BGW (1978) Mitogen responsiveness and suppressor cell function in multiple sclerosis. Neurology 28:999PubMedGoogle Scholar
  6. 6.
    Bresnihan B, Jasin HE (1977) Suppressor function of peripheral blood mononuclear cells in normal individuals and patients with systemic lupus erythematosus. J Clin Invest 59:106PubMedCrossRefGoogle Scholar
  7. 7.
    Broder S, Poplack D, Whang-Peng J, Durm M, Goldman C, Muul L, Waldman TA (1978) Characterization of a suppressor cell leukemia. N Engl J Med 298:66PubMedCrossRefGoogle Scholar
  8. 8.
    Goust JM, Carnes JE, Chenais F, Haimes CG, Fudenberg HH, Hogan EL (1978) Abnormal T-cell subpopulations and circulating immune complexes in the Guillain-Barre syndrome and multiple sclerosis. Neurology (Minneap) 28:421Google Scholar
  9. 9.
    Green JA, Copperband SR, Rutstein JA, Kibrick S (1970) Inhibition of target cell proliferation by supernatants from cultures of human peripheral lymphocytes. J Immunol 105:48PubMedGoogle Scholar
  10. 10.
    Horowitz S, Borcherding W, Moorthy AV, Chesney R, Schulte-Wissermann H, Hong R, Goldstein A (1977) Induction of suppressor T cells in systemic lupus erythematosus by thymosin and cultured thymic epithelium. Science 197:999PubMedCrossRefGoogle Scholar
  11. 11.
    Krakauer RS, Strober W, Rippeon DL, Waldman TA (1977) Prevention of autoimmunity in experimental lupus erythematosus by soluble immune response suppressor. Science 196:56PubMedCrossRefGoogle Scholar
  12. 12.
    Moretta L, Webb SR, Grossi CE, Hydyard PM, Cooper MD (1977) Functional analysis of two human T-cell subpopulations — help and suppression of B-cell responses by T cells bearing receptors for IgM (T M) or IgG (T G )J Exp Med 146:184PubMedCrossRefGoogle Scholar
  13. 13.
    Noronha AB, Richman DP, Atchley CE, Arnason BGW (to be published) Detection of in vivo stimulated cerebrospinal fluid lymphocytes in multiple sclerosis by flow cytofluorometryGoogle Scholar
  14. 14.
    Oger JF, Arnason BGW, Wray SH, Kistler P (1975) A study of B and T cells in multiple sclerosis. Neurology (Minneap) 25:444Google Scholar
  15. 15.
    Richman DP, Dropcho EJ, Antel JP, Arnason BGW (to be published) Contrasting defects of T-lymphocyte mitogenic response in multiple sclerosis and myasthenia gravis. Trans Am Neurol AssocGoogle Scholar
  16. 16.
    Sakane T, Green I (1977) Human suppressor T cells induced by concanavalin A: Suppressor T cells belong to distinctive T cell subclasses. J Immunol 119:1169PubMedGoogle Scholar
  17. 17.
    Shou L, Schwartz SA, Good RA (1976) Suppressor cell activity after concanavalin A treatment of lymphocytes from normal donors. J Exp Med 143:1100PubMedCrossRefGoogle Scholar
  18. 18.
    Siegal FP, Siegal M, Good RA (1977) Role of helper, suppressor and B-cell defects in the pathogenesis of the hypogammaglobulinemias. N Engl J Med 299:172CrossRefGoogle Scholar
  19. 19.
    Tada T, Taniguchi M, David CS (1976) Properties of the antigen-specific suppressive T-cell factor in the regulation of antibody response of the mouse IV. Special subregion assignment of the gene(s) that codes for the suppressive T cell factor in the H-2 histocompatibility system. J Exp Med 144:713PubMedCrossRefGoogle Scholar
  20. 20.
    Waldman TA, Broder S, Blaise RM, Durm M, Blackman M, Strober W (1974) Role of suppressor T cells in pathogenesis of common variable hypogammaglobulinemia. Lancet II:609CrossRefGoogle Scholar
  21. 21.
    Williams RC Jr, Korsmeyer SJ (1978) Studies of human lymphocyte interaction with emphasis on soluble suppressor activity. Clin Immunol Immunopathol 9:335PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1980

Authors and Affiliations

  • J. P. Antel
  • B. W. Arnason
    • 1
  1. 1.Department of Neurology, Division of the Biological SciencesPritzker School of Medicine of the University of ChicagoChicagoUSA

Personalised recommendations